• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    CVS Health Corp (NY: CVS )

    55.81 -0.65 (-1.15%)
    Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CVS Health Corp

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    47 48 Next >
    This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
    Via Benzinga
    Bernie Sanders And AOC Clap Back At Mark Cuban's Push for FCC Chief Shakeup: 'Anyone Goes Near Lina Khan And There Will Be An Out And Out Brawl'
    Alexandria Ocasio-Cortez and Bernie Sanders have strongly defended FTC chief Lina Khan and opposed Mark Cuban's suggestions that she be replaced if Kamala Harris becomes president. 
    Via Benzinga
    Exposures Regulatory
    CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
    The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that inflate insulin prices. The complaint claims the PBMs' focus on rebates raises... 
    Via Benzinga
    Biotech Stocks Poised For Another Big Move In Q4
    The healthcare sector can be a safe haven if volatility increases. 
    Via Talk Markets
    Looking Into CVS Health's Recent Short Interest
    Via Benzinga
    Looking At CVS Health's Recent Unusual Options Activity
    Via Benzinga
    Unpacking the Latest Options Trading Trends in CVS Health
    Via Benzinga
    What Analysts Are Saying About CVS Health Stock
    Via Benzinga
    Does This New Development Make CVS Stock a Buy or a Sell?
    Major changes could soon be coming, but will they drive the stock up? 
    Via The Motley Fool
    Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
    The stock could be poised for a turnaround. 
    Via The Motley Fool
    An Activist Investor Is Interested in CVS; We Take a Look
    We also chat about Uber and its quest to become an everything app. 
    Via The Motley Fool
    This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
    Via Benzinga
    Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    Stock Of The Day: Is It Time To Sell CVS?
    The chart of CVS (CVS) shows two important market principles. There tends to be resistance at former peaks and support at former bottoms. 
    Via Benzinga
    CVS Health's Options: A Look at What the Big Money is Thinking
    Via Benzinga
    Spotlight on CVS Health: Analyzing the Surge in Options Activity
    Via Benzinga
    Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
    Texas Attorney General Ken Paxton sues major insulin manufacturers and PBMs, accusing them of conspiring to inflate insulin prices by as much as 1,000%, violating Texas law and harming diabetes... 
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
    Humana Medicare Advantage plans are getting a big star-ratings cut. 
    Via Investor's Business Daily
    CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
    CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017. 
    Via Benzinga
    Instacart Is Revolutionizing Groceries: Why It's Time to Invest
    It can be confusing, but Maplebear Inc. (NASDAQ: CART) is better known as Instacart, the world's largest online grocery marketplace. 
    Via MarketBeat
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Is CVS Health Stock a Buy?
    It's been a year to forget for the healthcare company. 
    Via The Motley Fool
    Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today
    U.S. markets closed Monday slightly higher, with the Dow Jones Industrial Average edging up 0.04% to 42,330.15. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    CVS Health in Focus as Activist Investor Prepares for High-Level Talks
    CVS Health is under pressure from hedge fund Glenview Capital as the company grapples with stock price drops, financial struggles with Medicare, and legal scrutiny of its pharmacy-benefit unit. 
    Via Benzinga
    CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Here’s Why Surgery Partners Could Be the Next Hot Takeover
    Surgery Partners is the third-largest operator of ambulatory surgery centers (ASCs) in the United States, with over 200 locations. 
    Via MarketBeat
    Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
    The FTC is going after these PBMs. Is this an opportunity for investors? 
    Via The Motley Fool
    UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
    Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices. 
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
    FTC files a complaint against CVS, Cigna, and UnitedHealth's PBMs, accusing them of inflating insulin prices through a rebate-driven system. The case aims to address unfair practices and improve access... 
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
    Eli Lilly appeals a $183 million judgment in a Medicaid fraud case, arguing that it followed a reasonable interpretation of the law. The case has drawn attention from major business and pharmaceutical... 
    Via Benzinga
    Topics Fraud
    Exposures Legal
    Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    47 48 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.